Transaction in Own Shares

Summary by AI BETAClose X

On October 15, 2025, GSK plc, acting through BNP Paribas SA, purchased 405,500 of its own ordinary shares with a nominal value of 31¼ pence each. The lowest price paid per share was 1,608.00p, while the highest price was 1,633.00p, resulting in a volume-weighted average price of 1,617.97p per share. These shares will be held as Treasury shares, as part of the company's existing buyback program announced on September 30, 2025. Since that date, GSK has purchased a total of 3,919,500 ordinary shares. Following this transaction, GSK will hold 251,384,344 ordinary shares in treasury and have 4,064,029,485 ordinary shares in issue, excluding Treasury shares; the percentage of voting rights attributable to ordinary shares held in treasury is 6.19 per cent.

Disclaimer*

Companies

GSK (GSK)
UK 100
FTSE quotes by TradingView

Latest directors dealings

All directors dealings today